Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord...
Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors
About this item
Full title
Author / Creator
Majhail, N S , Brunstein, C G , Shanley, R , Sandhu, K , McClune, B , Oran, B , Warlick, E D , Wagner, J E and Weisdorf, D J
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Umbilical cord blood (UCB) has increased access to hematopoietic cell transplantation (HCT) for patients without HLA-matched sibling donors (MSD). We compared outcomes of HCT using MSD (
N
=38) or UCB (
N
=60) among older patients (age ⩾55 years) with AML or myelodysplastic syndromes (MDS). All patients received a reduced intensity regi...
Alternative Titles
Full title
Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4107640
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4107640
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/bmt.2011.114
